StudyGraphics #VisualAbstract Reduced-dose lenalidomide regimen significantly prolongs event-free survival in elderly, intermediate-fit patients with newly diagnosed multiple myeloma June 11, 2021 | Kathleen Lau Facebook Twitter Pinterest WhatsApp Linkedin ReddIt Email Print RELATED ARTICLESMORE FROM AUTHOR #VisualAbstract: Upadacitinib plus topical corticosteroids is safe and effective for moderate-to-severe atopic dermatitis; #VisualAbstract: Annual screening for ovarian cancer does not significantly reduce mortality #VisualAbstract: Preterm formula is similarly effective to human milk fortifiers as breastmilk supplement
